Johnson & Johnson Will Pay $7.8M to Settle Arkansas Lawsuit
Court filings show pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over how the company marketed an antipsychotic drug to Arkansas doctors.
The Arkansas Democrat-Gazette reported $2 million will go to a Texas law firm that represented Arkansas in the suit, which began more than seven years ago.
A Pulaski County jury ruled three years ago that the company, through its Janssen Pharmaceutical subsidiary, committed Medicaid fraud and violated a state law in its labeling and marketing of Risperdal. A $1.2 billion fine was imposed on Johnson & Johnson, but it was later overturned by the Arkansas Supreme Court.
Janssen representative Michelle Bauer said Monday that the settlement isn’t an admission of liability.
- Fannie and Freddie Hit Pause on Replacement-Value Requirements for Home Insurance
- Lindberg Convicted in Second Trial on Attempting to Bribe NC Insurance Commissioner
- Boat Found in Key Biscayne Incident That Killed 15-Year-Old Skiier
- High Court: E-Scooter Rider Hit by Car Not Eligible for No-Fault PIP Benefits